Hepatopancreatoduodenectomy for cholangiocarcinoma: A single-center review of 85 consecutive patients

Annals of Surgery

Volumn 256, Issue 2, 2012, Pages 297-305

  Ebata, Tomoki ^a   Yokoyama, Yukihiro ^a   Igami, Tsuyoshi ^a   Sugawara, Gen ^a   Takahashi, Yu ^a   Nimura, Yuji ^b   Nagino, Masato ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

cholangiocarcinoma; hepatopancreatoduodenectomy

Indexed keywords

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADULT; AGED; ARTICLE; ASCITES; BACTEREMIA; BILE DUCT CARCINOMA; BILE LEAKAGE; BLEEDING; CHOLANGITIS; ENTERITIS; FEMALE; GASTRIC DYSMOTILITY; HEPATOPANCREATODUODENECTOMY; HUMAN; LAPAROTOMY; LIVER FAILURE; LIVER RESECTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEGACOLON; MORBIDITY; OPERATION DURATION; OVERALL SURVIVAL; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PERITONITIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROBABILITY; REOPERATION; RETROSPECTIVE STUDY; STOMACH EMPTYING; SURGICAL MORTALITY; SURVIVAL RATE; VASCULAR SURGERY; WOUND DEHISCENCE; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 84863827546     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31826029ca     Document Type: Article

References (51)

1. Sakamoto E, Nimura Y, Hayakawa N, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg. 1998;227:405-411. (Pubitemid 28131022)
2. Ebata T, Watanabe H, Ajioka Y, et al. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg. 2002;89:1260-1267. (Pubitemid 36002543)
3. Kayahara M, Nagakawa T, Ohta T, et al. Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg 1999;229:76-83. (Pubitemid 30190383)
4. Ebata T, Kamiya J, Nishio H, et al. The concept of perihilar cholangiocarcinoma is valid. Br J Surg. 2009;96:926-934.
5. Igami T, Nagino M, Oda K, et al. Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg. 2009;249:296-302.
6. Nagino M, Nimura Y, Nishio H, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010;252:115-123.
7. Takasaki K, Kobayashi S, Mutoh H, et al. Our experiences (5 cases) of extended right lobectomy combined with pancreato-duodenectomy for the carcinoma of the gall bladder (in Japanese). Tan to Sui. 1980;1:923-932.
8. Nimura Y, Hayakawa N, Kamiya J, et al. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology. 1991;38:170-175.
9. Tsukada K, Yoshida K, Aono T, et al. Major hepatectomy and pancreatoduodenectomy for advanced carcinoma of the biliary tract. Br J Surg. 1994;81:108-110. (Pubitemid 24048956)
10. Nakamura S, Nishiyama R, Yokoi Y, et al. Hepatopancreatoduodenectomy for advanced gallbladder carcinoma. Arch Surg. 1994;129:625-629. (Pubitemid 24179207)
11. Miyagawa S, Makuuchi M, Kawasaki S, et al. Outcome of major hepatectomy with pancreatoduodenectomy for advanced biliary malignancies. World J Surg. 1996;20:77-80. (Pubitemid 26006202)
12. Yoshimi F, Asato Y, Amemiya R, et al. Comparison between pancreatoduodenectomy and hepatopancreatoduodenectomy for bile duct cancer. Hepatogastroenterology. 2001;48:994-998. (Pubitemid 32757726)
13. Hirono S, Tani M, Kawai M, et al. Indication of hepatopancreatoduodenectomy for biliary tract cancer. World J Surg. 2006;30:567-573; discussion 574-575.
14. Wakai T, Shirai Y, Tsuchiya Y, et al. Combined major hepatectomy and pancreaticoduodenectomy for locally advanced biliary carcinoma: long-term results. World J Surg. 2008;32:1067-1074.
15. Kaneoka Y, Yamaguchi A, Isogai M, et al. Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy. World J Surg. 2010;34:2662-2670.
16. D'Angelica M, Martin RC, II, Jarnagin WR, et al. Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. J Am Coll Surg. 2004;198:570-576. (Pubitemid 38446531)
17. Hemming AW, Magliocca JF, Fujita S, et al. Combined resection of the liver and pancreas for malignancy. J Am Coll Surg. 2010;210:808-814, 814-816.
18. Ebata T, Nagino M, Nishio H, et al. Right hepatopancreatoduodenectomy: improvements over 23 years to attain acceptability. J Hepatobiliary Pancreat Surg. 2007;14:131-135. (Pubitemid 46502138)
19. Nagino M, Nimura Y, Kamiya J, et al. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology. 1996;200:559-563. (Pubitemid 26249916)
20. Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364-372. (Pubitemid 43327769)
21. Yokoyama Y, Nishio H, Ebata T, et al. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97:1260-1268.
22. Nagino M, Kamiya J, Arai T, et al. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery. 2005;137:148-155. (Pubitemid 40174421)
23. Kamiya S, Nagino M, Kanazawa H, et al. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Ann Surg. 2004;239:510-517. (Pubitemid 38372767)
24. Sugawara G, Nagino M, Nishio H, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244:706-714. (Pubitemid 44629944)
25. Nimura Y, Hayakawa N, Kamiya J, et al. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14:535-543; discussion 544.
26. Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720-727. (Pubitemid 38182264)
27. Okusaka T, Ishii H, Funakoshi A, et al. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol. 2006;57:647-653. (Pubitemid 43237850)
28. Furuse J, Okusaka T, Boku N, et al. S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study. Cancer Chemother Pharmacol. 2008;62:849-855.
29. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463-473; discussion 473-475.
30. Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg. 1988;12:39-47. (Pubitemid 18074502)
31. Henson DE, Albores-Saavedra J, Compton CC. Protocol for the examination of specimens from patients with carcinomas of the extrahepatic bile ducts, exclusive of sarcomas and carcinoid tumors: a basis for checklists. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 2000;124:26-29. (Pubitemid 30053769)
32. Todoroki T, Okamura T, Fukao K, et al. Gross appearance of carcinoma of the main hepatic duct and its prognosis. Surg Gynecol Obstet. 1980;150:33-40. (Pubitemid 10211719)
33. Jarnagin WR, Bowne W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg. 2005;241:703-712; discussion 712-714.
34. Greene FL, Page DL, Flemming ID, et al. AJCC Cancer Staging Manual. New York, NY: Springer-Verlag; 2002:145-150.
35. Wakai T, Shirai Y, Moroda T, et al. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005;103:1210-1216. (Pubitemid 40328092)
36. Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713-724.
37. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8-13. (Pubitemid 40933766)
38. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213. (Pubitemid 38963009)
39. Miwa S, Kobayashi A, Akahane Y, et al. Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy? J Hepatobiliary Pancreat Surg. 2007;14:136-141. (Pubitemid 46502139)
40. Sakamoto Y, Shimada K, Nara S, et al. Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients. J Gastrointest Surg. 2010;14:335-343.
41. Dindo D, Muller MK, Weber M, et al. Obesity in general elective surgery. Lancet. 2003;361:2032-2035. (Pubitemid 36695045)
42. Yoshiike N, Seino F, Tajima S, et al. Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976-95. Obes Rev. 2002;3:183-190. (Pubitemid 34815237)
43. Unno M, Katayose Y, Rikiyama T, et al. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17:463-469.
44. Hirano S, Kondo S, Tanaka E, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci. 2010; 17:455-462.
45. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451-458; discussion 458-461.
46. Hemming AW, Reed AI, Fujita S, et al. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693-639; discussion 699-702.
47. Nakanishi Y, Kondo S, Zen Y, et al. Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. J Hepatobiliary Pancreat Sci. 2010;17:166-173.
48. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. New York, NY: Springer-Verlag; 2010:219-233.
49. Bhuiya MR, Nimura Y, Kamiya J, et al. Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg. 1993;17:653-657. (Pubitemid 23331443)
50. Hong SM, Kim MJ, Pi DY, et al. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients. Cancer. 2005;104:802-810. (Pubitemid 41113681)
51. Ebata T, Nagino M, Nishio H, et al. Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American Joint Committee on Cancer. World J Surg. 2007;31:2008-2015. (Pubitemid 47415717)